» News  

Latest News  Latest News

Paris: Albutec at EASL ILC 2018

published on 20.04.2018

 
Albutec EASL ILC

Albutec supported Europe's largest liver congress (EASL ILC 2018) this year and was represented as an industrial exhibitor with its own stand.

 

The EASL ILC took place this year from 11 to 15 April at the EXPO site in Paris.

 

In addition to the industrial exhibition, Albutec was also able to present its latest development to interested experts at a workshop for extracorporeal liver support.

 

In Albutec's view, the presentation of clinical data from the OPALESCE study by Dr. Jan Stange was of special value. The presented data (see Abstract EASL ILC 2018 Poster) show that the Hepalbin-Cluster12 within the OPAL system improves the albumin binding function (ABF) of plasma albumin in the liver patient.

sponsors albutec EASL ILC

 
Do you have a specific question?
Please try us:

 

Albutec GmbH
Phone: +49-381-12165871
Fax: +49-381-12165877
Email: info@albutec.de

 

Albutec GmbH  Schillingallee 68  18057 Rostock  Germany     Phone: +49-381-12165871    Fax: +49-381-12165877